Formycon AG (HAM:FYB) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 11, 2026)


HAM:FYB Formycon AG HAM:FYB
60 GF Score
Price €18.98
GF Value €37.06
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Formycon AG Float Percentage Of Total Shares Outstanding?

Formycon AG HAM:FYB +3.83% 60 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 11, 2026. GuruFocus rates HAM:FYB with a GF Score™ of 60/100 and a GF Value™ of €37.06 (Possible Value Trap). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Formycon AG's float shares is 0.00 Mil. Formycon AG's total shares outstanding is 17.67 Mil. Formycon AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Formycon AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Formycon AG's Institutional Ownership is 0.96%.

HAM:FYB
60GF Score
Formycon AG HAM:FYB
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Formycon AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Formycon AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/17.67
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Formycon AG (HAM:FYB) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Formycon AG and its competitors.
Is Formycon AG's Float Percentage Of Total Shares Outstanding too high?
Formycon AG's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Formycon AG has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formycon AG's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Formycon AG's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Formycon AG and its competitors. Formycon AG's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formycon AG stock overvalued right now?
Based on GuruFocus' analysis, Formycon AG (HAM:FYB) is currently considered Possible Value Trap. The stock's GF Value™ is €37.06, compared to a current price of €18.98 — trading 48.8% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Formycon AG's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Formycon AG (HAM:FYB), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Formycon AG (HAM:FYB) Overvalued in 2026?

Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued. The current stock price of €18.98 is trading 48.8% below its estimated GF Value™ of €37.06. GuruFocus considers Formycon AG to be Possible Value Trap.

Key valuation signals for HAM:FYB:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €37.06 vs. price of €18.98 (48.8% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the HAM:FYB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Formycon AG Business Description

Address Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
60GF Score

Get the complete analysis for HAM:FYB

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.98
Price
€37.06
GF Value